Crossmark

Evaluation of the Safety, Tolerability, and Immunogenicity of an Oral, Inactivated Whole-Cell Shigella flexneri 2a Vaccine in Healthy Adult Subjects

Crossref DOI link: https://doi.org/10.1128/CVI.00608-15

Published Print: 2016-04

Update policy: https://doi.org/10.1128/asmj-crossmark-policy-page

Authors

Chakraborty, Subhra

Harro, Clayton

DeNearing, Barbara

Bream, Jay

Bauers, Nicole

Dally, Len

Flores, Jorge

Van de Verg, Lillian

Sack, David A.

Walker, Richard
Funding

Funding for this research was provided by:

PATH (GAT.1371-08887-CTA)
License Information

Text and Data Mining valid from 2016-04-01
More Information

Publication History

Received: 2015-10-23

Accepted: 2016-02-02

Published: 2016-04-04